DiNuzzo Private Wealth’s Haemonetics HAE Stock Holding History

DiNuzzo Private Wealth’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$525	Buy	7 +4	+133%	+$257	﹤0.01%	1091
2026 Q1	$170	Sell	3 -7	-70%	-$456	﹤0.01%	1251
2025 Q4	$802	Buy	10 +5	+100%	+$336	﹤0.01%	941
2025 Q3	$273	Sell	5 -3	-38%	-$186	﹤0.01%	1225
2025 Q2	$597	Sell	8 -1	-11%	-$66	﹤0.01%	1021
2025 Q1	$572	Sell	9 -1	-10%	-$68	﹤0.01%	1004
2024 Q4	$781	Buy	10 +3	+43%	+$241	﹤0.01%	934
2024 Q3	$563	Sell	7 -2	-22%	-$162	﹤0.01%	1068
2024 Q2	$745	Buy	9 +1	+13%	+$88	﹤0.01%	906
2024 Q1	$683	Sell	8 -2	-20%	-$157	﹤0.01%	867
2023 Q4	$856	Buy	+10	New	+$865	﹤0.01%	768

Other funds holding HAE

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DiNuzzo Private Wealth's HAE Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Haemonetics (HAE) stake by 133% in Q2 2026, buying an estimated $257 and bringing the position to 7 shares worth $525. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

DiNuzzo Private Wealth first reported a position in HAE in Q4 2023 and has held it in 11 quarters since. The position peaked at $856 in Q4 2023. 31 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

DiNuzzo Private Wealth held 7 shares of Haemonetics worth $525 as of Q2 2026.
DiNuzzo Private Wealth bought 4 Haemonetics shares in Q2 2026, an estimated $257.
Haemonetics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1091 holding.
DiNuzzo Private Wealth first reported a position in Haemonetics in Q4 2023 and has held it in 11 quarters since.
DiNuzzo Private Wealth's Haemonetics position peaked at $856 in Q4 2023.
31 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.